ClinicalTrials.Veeva

Menu

Impact of Analgesia on Success of External Version: Comparison of Spinal Anesthesia Versus Sedation (RaVem)

C

Centre Hospitalier Universitaire, Amiens

Status and phase

Unknown
Phase 3

Conditions

Breech Presentation

Treatments

Drug: Midazolam
Drug: Bupivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT02801201
PI2016_843_0001

Details and patient eligibility

About

At the time of birth, nearly 5% of children are in breech presentation. This type of presentation requires a medical environment and leads to more frequent use of Caesarean sections. This is why the external version can be proposed, usually from the 36th week. Its success rate is 40%, and is usually performed under simple sedation. One of the causes of failure is the lack of relaxation of the uterus, which could be higher in case of deeper anesthesia, as is the case in spinal anesthesia. The study project is to demonstrate superiority of spinal anesthesia compared to the usual protocol sedation in terms of primary and secondary objectives.

Enrollment

200 estimated patients

Sex

Female

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age ≥ 18 years
  • patient with 36 weeks of amenorrhea (SA) a fetus breech or transverse presentation
  • covered by a an insurance system
  • signed contentment

Exclusion criteria

Obstetric contraindications:

  • placenta previa
  • 3rd trimester bleeding
  • suspicion of fetal anoxia
  • patient has already received more than one caesarean section
  • multi-fetal pregnancy
  • HIV +
  • anticoagulant therapy

Anesthesiologic contraindications:

  • infection at the puncture site, systemic infection or severe sepsis
  • intracranial hypertension
  • uncompensated heart failure
  • constitute or acquired coagulation abnormalities, including anticoagulant therapy with curative intent
  • neuropathy with demyelination of nerve fibers in thrust or unstabilized during recovery
  • syringomyelia

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups

sedation
Active Comparator group
Description:
Midazolam : 0,10 mg/kg
Treatment:
Drug: Midazolam
spinal anesthesia
Active Comparator group
Description:
Bupivacain 10 mg
Treatment:
Drug: Bupivacaine

Trial contacts and locations

1

Loading...

Central trial contact

Julien CHEVREAU, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems